These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 24763226)
1. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226 [TBL] [Abstract][Full Text] [Related]
2. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC. Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847 [TBL] [Abstract][Full Text] [Related]
3. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway. Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025 [TBL] [Abstract][Full Text] [Related]
4. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1. Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330 [TBL] [Abstract][Full Text] [Related]
5. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling. He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430 [TBL] [Abstract][Full Text] [Related]
6. Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving uPA/uPAR signaling. Li CZ; Qiang YY; Liu ZJ; Zheng LS; Peng LX; Mei Y; Meng DF; Wei WW; Chen DW; Xu L; Lang YH; Xie P; Peng XS; Wang MD; Guo LL; Shu DT; Ding LY; Lin ST; Luo FF; Wang J; Li SS; Huang BJ; Chen JD; Qian CN Drug Dev Res; 2023 Nov; 84(7):1468-1481. PubMed ID: 37534761 [TBL] [Abstract][Full Text] [Related]
7. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790 [TBL] [Abstract][Full Text] [Related]
8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
9. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma. Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923 [TBL] [Abstract][Full Text] [Related]
10. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923 [TBL] [Abstract][Full Text] [Related]
11. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy. Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000 [TBL] [Abstract][Full Text] [Related]
12. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression. Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810 [TBL] [Abstract][Full Text] [Related]
13. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis. Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772 [TBL] [Abstract][Full Text] [Related]
15. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728 [TBL] [Abstract][Full Text] [Related]
16. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway. Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576 [TBL] [Abstract][Full Text] [Related]
17. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma. Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775 [TBL] [Abstract][Full Text] [Related]
18. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742 [TBL] [Abstract][Full Text] [Related]
19. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [TBL] [Abstract][Full Text] [Related]
20. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β. Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]